首页> 外文期刊>Journal of environmental biology >Anticancer activity of Callicarpa arborea Roxb. extracts against Type-Ⅱ human lung adenocarcinoma cell line, A549
【24h】

Anticancer activity of Callicarpa arborea Roxb. extracts against Type-Ⅱ human lung adenocarcinoma cell line, A549

机译:Callicarpa arborea roxb的抗癌活动。针对Ⅱ型人肺腺癌细胞系提取物,A549

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aim: The study aims to evaluate the anticancer activity of Callicarpa arborea in A549 cancer cells.Methodology: Fresh non-infected leaves of Callicarpa arborea were collected from Serkawn, Lunglei District, Mizoram and various solvents were used for Soxhlet extraction at their respective boiling points. The extracts were concentrated and the anticancer activity was tested in the human lung cancer cell line A549 using MTT and clonogenic assays. The effect of C. arborea on the antioxidant system was also assessed by measuring the levels of glutathione, glutathione s-transferases, superoxide dismutase as well as lipid peroxidation levels following standard protocols.Results: Among the various solvent extracts of C. arborea, only chloroform extract showed significant cytotoxicity, and inhibited cell proliferation and survival against the A549 cancer cells. The chloroform extract of C. arborea induced cell death in A549 cells in a dose and time dependent manner with an IC50 of 52.8 mu gml(-1) and 20.4 mu gml(-1) at 24 hr and 48 hr, respectively. The clonogenic assay showed that the chloroform extract was able to inhibit cell proliferation in the A549 cells and the inhibition increased with increase in dose. The chloroform extract also alleviated the levels and activities of antioxidants glutathione, glutathione-s-transferase and superoxide dismutase, while elevating the lipid peroxidation level in the A549 cells.Interpretation: The study shows that Callicarpa arborea possess both cytotoxic and anti-proliferative properties against the human lung cancer cell line A549. Callicarpa arborea is a potential candidate as a new anti-cancer agent and warrants further investigation.
机译:目的:该研究旨在评估A549癌细胞中愈伤组织植物植物的抗癌活动。药物学:从Serkawn,Munglei区,Mizoram和各种溶剂中收集了新鲜的无感染叶片,在各自的沸点上用于Soxhlet提取。 。浓缩萃取物,使用MTT和克隆原测定,在人肺癌细胞系A549中测试抗癌活性。通过测量标准方案后,还通过测量谷胱甘肽,谷胱甘肽S-转移酶,超氧化术水平,过氧化物歧化水平的抗氧化体系对抗氧化系统的影响。结果:仅限C.Alborea的各种溶剂提取物中,仅氯仿提取物显示出显着的细胞毒性,并抑制细胞增殖和对A549癌细胞的存活率。 C.Arborea的氯仿提取物在A549细胞中诱导细胞死亡剂量和时间依赖性方式,IC50分别在24小时和48小时的24.8μg(-1)和20.4μgmml(-1)。克隆致睾丸测定表明,氯仿提取物能够在A549细胞中抑制细胞增殖,并且随着剂量增加而增加抑制。氯仿提取物也缓解了抗氧化剂谷胱甘肽,谷胱甘肽-S-转移酶和超氧化物歧化酶的水平和活性,同时升高了A549细胞中的脂质过氧化水平。诠释结果:该研究表明,Callicarpa arborea具有细胞毒性和抗增殖性能人肺癌细胞系A549。 Callicarpa Arborea是一种潜在的候选人,作为一种新的抗癌剂,并认证进一步调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号